Mayank Sardana is a Cardiology physician affiliated with WinnMed. OpenAlex indexes 92 publications with 22,297 citations (h-index 20). By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13400 E Shea Blvd
Scottsdale, AZ 852595499
Telephone
480-301-8000Provider last certified this registry record 5 Oct 2023.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
- Biosense Webster, Inc.Program year20251 payment
- Medtronic, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.2%Antiarrhythmic39.5%Amiodarone Hcl53%Flecainide Acetate47%Part D<11 patientsBeta blocker38.7%Metoprolol Succinate52%Carvedilol24%Metoprolol Tartrate24%Part D<11 patientsBlood & clotting
21.8%Factor Xa inhibitor21.8%Eliquis100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Elevated lipoprotein(a) levels linked to new-onset atrial fibrillation: insights from a retrospective cohort study
European Journal of Preventive Cardiology
2025 - Safety, Efficacy, and Mid-Term Outcomes of Pulsed Field Ablation for Cavotricuspid Isthmus–Dependent Flutter: Real-World Data From a Major Health System Registry
Circulation Arrhythmia and Electrophysiology
2025 - Evaluation of CACNA1C-Positive Patients Evaluated in a Tertiary Genetic Heart Rhythm Clinic
Journal of Cardiovascular Translational Research
2025 - Unexplained sudden cardiac arrest and sudden cardiac death in the young: What is killing these young people when nothing is found?
Trends in Cardiovascular Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Saurabh Chhabra, MD
WinnMed
Keith Oken, MD
WinnMed
Channa Jayasekera, MD, MS, MSc
WinnMed
Rakesh Suri, MD
WinnMed
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”